Influenza vaccination guidelines and vaccine sales in southeast Asia: 2008-2011.
BACKGROUND: Southeast Asia is a region with great potential for the emergence of a pandemic influenza virus. Global efforts to improve influenza surveillance in this region have documented the burden and seasonality of influenza viruses and have informed influenza prevention strategies, but little i...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3528727?pdf=render |
id |
doaj-212eaec5749b4361be12a80b890984bc |
---|---|
record_format |
Article |
spelling |
doaj-212eaec5749b4361be12a80b890984bc2020-11-25T02:00:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e5284210.1371/journal.pone.0052842Influenza vaccination guidelines and vaccine sales in southeast Asia: 2008-2011.Vinay GuptaFatimah S DawoodCharung MuangchanaPhan Trong LanAnonh XeuatvongsaLy SovannRemigio OlvedaJeffery CutterKhin Yi OoTheresia Sandra Diah RatihChong Chee KheongBryan K KapellaPaul KitsutaniAndrew CorwinSonja J OlsenBACKGROUND: Southeast Asia is a region with great potential for the emergence of a pandemic influenza virus. Global efforts to improve influenza surveillance in this region have documented the burden and seasonality of influenza viruses and have informed influenza prevention strategies, but little information exists about influenza vaccination guidelines and vaccine sales. METHODS: To ascertain the existence of influenza vaccine guidelines and define the scope of vaccine sales, we sent a standard three-page questionnaire to the ten member nations of the Association of Southeast Asian Nations. We also surveyed three multinational manufacturers who supply influenza vaccines in the region. RESULTS: Vaccine sales in the private sector were <1000 per 100,000 population in the 10 countries. Five countries reported purchasing vaccine for use in the public sector. In 2011, Thailand had the highest combined reported rate of vaccine sales (10,333 per 100,000). In the 10 countries combined, the rate of private sector sales during 2010-2011 (after the A(H1N1)2009pdm pandemic) exceeded 2008 pre-pandemic levels. Five countries (Indonesia, Malaysia, Singapore, Thailand and Vietnam) had guidelines for influenza vaccination but only two were consistent with global guidelines. Four recommended vaccination for health care workers, four for elderly persons, three for young children, three for persons with underlying disease, and two for pregnant women. CONCLUSIONS: The rate of vaccine sales in Southeast Asia remains low, but there was a positive impact in sales after the A(H1N1)2009pdm pandemic. Low adherence to global vaccine guidelines suggests that more work is needed in the policy arena.http://europepmc.org/articles/PMC3528727?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vinay Gupta Fatimah S Dawood Charung Muangchana Phan Trong Lan Anonh Xeuatvongsa Ly Sovann Remigio Olveda Jeffery Cutter Khin Yi Oo Theresia Sandra Diah Ratih Chong Chee Kheong Bryan K Kapella Paul Kitsutani Andrew Corwin Sonja J Olsen |
spellingShingle |
Vinay Gupta Fatimah S Dawood Charung Muangchana Phan Trong Lan Anonh Xeuatvongsa Ly Sovann Remigio Olveda Jeffery Cutter Khin Yi Oo Theresia Sandra Diah Ratih Chong Chee Kheong Bryan K Kapella Paul Kitsutani Andrew Corwin Sonja J Olsen Influenza vaccination guidelines and vaccine sales in southeast Asia: 2008-2011. PLoS ONE |
author_facet |
Vinay Gupta Fatimah S Dawood Charung Muangchana Phan Trong Lan Anonh Xeuatvongsa Ly Sovann Remigio Olveda Jeffery Cutter Khin Yi Oo Theresia Sandra Diah Ratih Chong Chee Kheong Bryan K Kapella Paul Kitsutani Andrew Corwin Sonja J Olsen |
author_sort |
Vinay Gupta |
title |
Influenza vaccination guidelines and vaccine sales in southeast Asia: 2008-2011. |
title_short |
Influenza vaccination guidelines and vaccine sales in southeast Asia: 2008-2011. |
title_full |
Influenza vaccination guidelines and vaccine sales in southeast Asia: 2008-2011. |
title_fullStr |
Influenza vaccination guidelines and vaccine sales in southeast Asia: 2008-2011. |
title_full_unstemmed |
Influenza vaccination guidelines and vaccine sales in southeast Asia: 2008-2011. |
title_sort |
influenza vaccination guidelines and vaccine sales in southeast asia: 2008-2011. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2012-01-01 |
description |
BACKGROUND: Southeast Asia is a region with great potential for the emergence of a pandemic influenza virus. Global efforts to improve influenza surveillance in this region have documented the burden and seasonality of influenza viruses and have informed influenza prevention strategies, but little information exists about influenza vaccination guidelines and vaccine sales. METHODS: To ascertain the existence of influenza vaccine guidelines and define the scope of vaccine sales, we sent a standard three-page questionnaire to the ten member nations of the Association of Southeast Asian Nations. We also surveyed three multinational manufacturers who supply influenza vaccines in the region. RESULTS: Vaccine sales in the private sector were <1000 per 100,000 population in the 10 countries. Five countries reported purchasing vaccine for use in the public sector. In 2011, Thailand had the highest combined reported rate of vaccine sales (10,333 per 100,000). In the 10 countries combined, the rate of private sector sales during 2010-2011 (after the A(H1N1)2009pdm pandemic) exceeded 2008 pre-pandemic levels. Five countries (Indonesia, Malaysia, Singapore, Thailand and Vietnam) had guidelines for influenza vaccination but only two were consistent with global guidelines. Four recommended vaccination for health care workers, four for elderly persons, three for young children, three for persons with underlying disease, and two for pregnant women. CONCLUSIONS: The rate of vaccine sales in Southeast Asia remains low, but there was a positive impact in sales after the A(H1N1)2009pdm pandemic. Low adherence to global vaccine guidelines suggests that more work is needed in the policy arena. |
url |
http://europepmc.org/articles/PMC3528727?pdf=render |
work_keys_str_mv |
AT vinaygupta influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT fatimahsdawood influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT charungmuangchana influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT phantronglan influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT anonhxeuatvongsa influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT lysovann influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT remigioolveda influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT jefferycutter influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT khinyioo influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT theresiasandradiahratih influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT chongcheekheong influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT bryankkapella influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT paulkitsutani influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT andrewcorwin influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 AT sonjajolsen influenzavaccinationguidelinesandvaccinesalesinsoutheastasia20082011 |
_version_ |
1724961718050750464 |